You are here
Block before Body
At Pfizer Rare Disease, we believe there's only one way to succeed - together. With the number of rare diseases, the lives affected and the potential discoveries, collaboration is the catalyst for progress. Pfizer Rare Disease works with a diverse range of stakeholders, including patients and their advocacy organizations.
In collaborating with advocacy associations, we build a collective body of expertise and shared resources that can, together, span the drug development continuum, speed the drug development process, and help meet the spectrum of community needs along the disease journey.
Our unique partnerships extend and further evolve the collaborative model. Together we are gaining greater knowledge faster, eliminating unproductive avenues of exploration sooner, and testing and improving potential new therapies more efficiently.